Sepsis is usually treated with intravenous fluids and antibiotics. Typically, antibiotics are given as soon as possible. Often, ongoing care is performed in an intensive care unit. If fluid replacement is not enough to maintain blood pressure, medications that raise blood pressure may be used. Mechanical ventilation and dialysis may be needed to support the function of the lungs and kidneys, respectively. To guide treatment, a central venous catheter and an arterial catheter may be placed for access to the bloodstream. Other measurements such as cardiac output and superior vena cava oxygen saturation may be used. People with sepsis need preventive measures for deep vein thrombosis, stress ulcers and pressure ulcers, unless other conditions prevent such interventions. Some might benefit from tight control of blood sugar levels with insulin. The use of corticosteroids is controversial, with some reviews finding benefit, and others not.
The global market for Sepsis Treatment was estimated to be worth US$ 3352.9 million in 2023 and is forecast to a readjusted size of US$ 5307.4 million by 2030 with a CAGR of 6.7% during the forecast period 2024-2030
Market competition is intense. Pfizer, NCPC, Bayer, Shanghai Pharmaceuticals, Johnson & Johnson, Novartis, GlaxoSmithKline etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Pfizer accounted for largest market share of about 3% in 2019.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sepsis Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Sepsis Treatment by region & country, by Type, and by Application.
The Sepsis Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Treatment.
Market Segmentation
By Company
Pfizer
NCPC
Bayer
Shanghai Pharmaceuticals
Johnson & Johnson
Novartis
GlaxoSmithKline
TEVA
Mylan
Allergan
Merck & Co
Asahi Kasei Corporation
AtoxBio
INOTREM
Adrenomed
Endacea
Segment by Type:
Cephalosporin
Pencillin
Macrolides
Others
Segment by Application
Sepsis
Severe Sepsis
Septic Shock
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sepsis Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Sepsis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Sepsis Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Sepsis Treatment Product Introduction
1.2 Global Sepsis Treatment Market Size Forecast
1.3 Sepsis Treatment Market Trends & Drivers
1.3.1 Sepsis Treatment Industry Trends
1.3.2 Sepsis Treatment Market Drivers & Opportunity
1.3.3 Sepsis Treatment Market Challenges
1.3.4 Sepsis Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sepsis Treatment Players Revenue Ranking (2023)
2.2 Global Sepsis Treatment Revenue by Company (2019-2024)
2.3 Key Companies Sepsis Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Sepsis Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Sepsis Treatment
2.6 Sepsis Treatment Market Competitive Analysis
2.6.1 Sepsis Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Sepsis Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cephalosporin
3.1.2 Pencillin
3.1.3 Macrolides
3.1.4 Others
3.2 Global Sepsis Treatment Sales Value by Type
3.2.1 Global Sepsis Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sepsis Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Sepsis Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Sepsis
4.1.2 Severe Sepsis
4.1.3 Septic Shock
4.2 Global Sepsis Treatment Sales Value by Application
4.2.1 Global Sepsis Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sepsis Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Sepsis Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Sepsis Treatment Sales Value by Region
5.1.1 Global Sepsis Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sepsis Treatment Sales Value by Region (2019-2024)
5.1.3 Global Sepsis Treatment Sales Value by Region (2025-2030)
5.1.4 Global Sepsis Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Sepsis Treatment Sales Value, 2019-2030
5.2.2 North America Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Sepsis Treatment Sales Value, 2019-2030
5.3.2 Europe Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Sepsis Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Sepsis Treatment Sales Value, 2019-2030
5.5.2 South America Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Sepsis Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Sepsis Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sepsis Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sepsis Treatment Sales Value
6.3 United States
6.3.1 United States Sepsis Treatment Sales Value, 2019-2030
6.3.2 United States Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sepsis Treatment Sales Value, 2019-2030
6.4.2 Europe Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sepsis Treatment Sales Value, 2019-2030
6.5.2 China Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sepsis Treatment Sales Value, 2019-2030
6.6.2 Japan Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sepsis Treatment Sales Value, 2019-2030
6.7.2 South Korea Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sepsis Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sepsis Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sepsis Treatment Sales Value, 2019-2030
6.9.2 India Sepsis Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sepsis Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer Sepsis Treatment Products, Services and Solutions
7.1.4 Pfizer Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 NCPC
7.2.1 NCPC Profile
7.2.2 NCPC Main Business
7.2.3 NCPC Sepsis Treatment Products, Services and Solutions
7.2.4 NCPC Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 NCPC Recent Developments
7.3 Bayer
7.3.1 Bayer Profile
7.3.2 Bayer Main Business
7.3.3 Bayer Sepsis Treatment Products, Services and Solutions
7.3.4 Bayer Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Shanghai Pharmaceuticals Recent Developments
7.4 Shanghai Pharmaceuticals
7.4.1 Shanghai Pharmaceuticals Profile
7.4.2 Shanghai Pharmaceuticals Main Business
7.4.3 Shanghai Pharmaceuticals Sepsis Treatment Products, Services and Solutions
7.4.4 Shanghai Pharmaceuticals Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Shanghai Pharmaceuticals Recent Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Profile
7.5.2 Johnson & Johnson Main Business
7.5.3 Johnson & Johnson Sepsis Treatment Products, Services and Solutions
7.5.4 Johnson & Johnson Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Johnson & Johnson Recent Developments
7.6 Novartis
7.6.1 Novartis Profile
7.6.2 Novartis Main Business
7.6.3 Novartis Sepsis Treatment Products, Services and Solutions
7.6.4 Novartis Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Novartis Recent Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Profile
7.7.2 GlaxoSmithKline Main Business
7.7.3 GlaxoSmithKline Sepsis Treatment Products, Services and Solutions
7.7.4 GlaxoSmithKline Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 GlaxoSmithKline Recent Developments
7.8 TEVA
7.8.1 TEVA Profile
7.8.2 TEVA Main Business
7.8.3 TEVA Sepsis Treatment Products, Services and Solutions
7.8.4 TEVA Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 TEVA Recent Developments
7.9 Mylan
7.9.1 Mylan Profile
7.9.2 Mylan Main Business
7.9.3 Mylan Sepsis Treatment Products, Services and Solutions
7.9.4 Mylan Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Mylan Recent Developments
7.10 Allergan
7.10.1 Allergan Profile
7.10.2 Allergan Main Business
7.10.3 Allergan Sepsis Treatment Products, Services and Solutions
7.10.4 Allergan Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Allergan Recent Developments
7.11 Merck & Co
7.11.1 Merck & Co Profile
7.11.2 Merck & Co Main Business
7.11.3 Merck & Co Sepsis Treatment Products, Services and Solutions
7.11.4 Merck & Co Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Merck & Co Recent Developments
7.12 Asahi Kasei Corporation
7.12.1 Asahi Kasei Corporation Profile
7.12.2 Asahi Kasei Corporation Main Business
7.12.3 Asahi Kasei Corporation Sepsis Treatment Products, Services and Solutions
7.12.4 Asahi Kasei Corporation Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Asahi Kasei Corporation Recent Developments
7.13 AtoxBio
7.13.1 AtoxBio Profile
7.13.2 AtoxBio Main Business
7.13.3 AtoxBio Sepsis Treatment Products, Services and Solutions
7.13.4 AtoxBio Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 AtoxBio Recent Developments
7.14 INOTREM
7.14.1 INOTREM Profile
7.14.2 INOTREM Main Business
7.14.3 INOTREM Sepsis Treatment Products, Services and Solutions
7.14.4 INOTREM Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 INOTREM Recent Developments
7.15 Adrenomed
7.15.1 Adrenomed Profile
7.15.2 Adrenomed Main Business
7.15.3 Adrenomed Sepsis Treatment Products, Services and Solutions
7.15.4 Adrenomed Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.15.5 Adrenomed Recent Developments
7.16 Endacea
7.16.1 Endacea Profile
7.16.2 Endacea Main Business
7.16.3 Endacea Sepsis Treatment Products, Services and Solutions
7.16.4 Endacea Sepsis Treatment Revenue (US$ Million) & (2019-2024)
7.16.5 Endacea Recent Developments
8 Industry Chain Analysis
8.1 Sepsis Treatment Industrial Chain
8.2 Sepsis Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sepsis Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Sepsis Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Pfizer
NCPC
Bayer
Shanghai Pharmaceuticals
Johnson & Johnson
Novartis
GlaxoSmithKline
TEVA
Mylan
Allergan
Merck & Co
Asahi Kasei Corporation
AtoxBio
INOTREM
Adrenomed
Endacea
*If Applicable.